BCG vaccine appears to protect patients with type 1 diabetes from COVID-19 infection
Multiple does of the Bacillus Calmette-Guerin (BCG) vaccine appears to offer patients with type 1 diabetes strong protection against COVID-19, researchers reported on August 15, 2022 in Cell Reports. “Multiple studies have shown that adults with type 1 diabetes who are diagnosed with COVID-19 are at increased risk of severe illness,” said lead Denise Faustman, MD, PhD, director of the […]
Recent Comments